3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
22
Neoplasms
13
Colonic Neoplasms
10
Breast Neoplasms
10
Venous Thromboembolism
8
Prostatic Neoplasms
8
Multiple Myeloma
7
Recurrence
6
Polycythemia Vera
6
Carcinoma, Non-Small-Cell Lung
6
Thrombocythemia, Essential
4
Neoplasms, Plasma Cell
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Thrombosis
2
Sarcoma
2
Rectal Neoplasms
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Myocardial Infarction
2
Lung Neoplasms
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammation
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Interventions
Blood Specimen Collection
7
Pentoxifylline
4
Liver Transplantation
4
Magnetic Resonance Spectroscopy
3
Tocopherols
2
Low-Level Light Therapy
2
High-Energy Shock Waves
2
tremelimumab
1
sonidegib
1
maltodextrin
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
apixaban
1
alpha-Tocopherol
1
Vitamin E
1
Vitamin D
1
User-Centered Design
1
Tenofovir
1
Surveys and Questionnaires
1
Sunitinib
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Sorafenib
1
Sonazoid
1
Sodium Chloride
1
Sampling Studies
1
Restraint, Physical
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fibrosis
×
Aspirin
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled